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Urticaria is a well-known disease entity; however,
with an increasing understanding of the molecular
mechanisms involved in its pathogenesis, there is
also growing evidence for a heterogeneity of urti-
caria. Currently it is sometimes dif®cult to compare
divergent data reported by different centers research-
ing urticaria due to a lack of precisely described
patient populations. A consensus de®nition and clas-
si®cation of the disease and its subtypes, taking into
account new developments, are therefore needed.
In addition, this consensus report provides a guide-
line for diagnostic procedures in different subtypes
of urticaria. Key words: autologous serum/chronic urti-
caria/etiology/wheal. Journal of Investigative Dermatology
Symposium Proceedings 6:123±127, 2001
T
his consensus report is the result of a panel discussion
during the International Clinically Oriented ESDR
Symposium ``Urticaria 2000''. The authors as mem-
bers of the panel had prepared their suggestions
regarding de®nition, classi®cation, and routine diag-
nosis of urticaria in advance. These suggestions were then discussed
in detail with the participants of the meeting using simple voting
systems. The participation of more than 100 specialists in urticaria
from over 15 countries ensured that this consensus includes any
regional differences in viewpoint and hopefully provides a basis for
improved comparison of future planned studies in the ®eld of
urticaria.
Urticaria was described as a distinct entity by Hippocrates, but
many different subtypes have been recognized during the past
century. With an increasing understanding of the molecular
mechanisms involved in its pathogenesis, there is also growing
evidence for a heterogeneity of urticaria. An updated de®nition and
classi®cation of urticaria, to include new developments, are
therefore needed. These should facilitate the interpretation of
divergent data from different centers regarding eliciting causes for
subtypes of urticaria and their therapeutic responsiveness.
DEFINITIONS
Clinical appearance Urticaria is characterized by the rapid
appearance of wheals, which may be accompanied by angioedema.
A wheal consists of three typical features: (i) a central swelling of
variable size, almost invariably surrounded by a re¯ex erythema; (ii)
associated itching or sometimes burning; (iii) its ¯eeting nature,
with the skin returning to its normal appearance usually within 1±
24 h.
Angioedema is de®ned by: (i) sudden, pronounced swelling of
the lower dermis and subcutis; (ii) sometimes pain rather than
itching; (iii) frequent involvement of mucous membranes; (iv) a
resolution of up to 72 h, which is slower than that for wheals.
Histologic aspects On histology, the classical ¯eeting wheal
demonstrates edema of the epidermis and the upper and mid-
dermis, with dilatation of the postcapillary venules and lymphatic
vessels of the upper dermis. In angioedema similar changes
primarily involve the lower dermis and the subcutis. Dependent
on the duration of the wheals, there is always an upregulation of
endothelial adhesion molecules, a mixed in¯ammatory perivascular
in®ltrate of variable intensity, consisting of neutrophils and/or
eosinophils, macrophages, and T-helper lymphocytes (Haas et al,
1998). A mild to moderate increase of mast cell numbers has also
been observed. In delayed pressure urticaria the in®ltrate is located
typically in the mid- to lower dermis (Barlow et al, 1994). In
different subtypes of urticaria, alterations of adhesion molecules
(Zuberbier et al, 1997) and cytokine expression is also seen in
uninvolved skin (Hermes et al, 1999).
These recent ®ndings underline the complex nature of the
pathogenesis of urticaria, which has many features in addition to
release of histamine from dermal mast cells. The changes are
generally also seen in other diverse in¯ammatory reactions and are
thus not speci®c or diagnostic. A search for more speci®c markers
for different subtypes of urticaria is desirable.
CLASSIFICATION OF URTICARIA ON THE BASIS OF
ITS DURATION, FREQUENCY, AND CAUSES
The spectrum of clinical manifestations of different urticaria
subtypes is very wide. Additionally, in one patient two or more
different subtypes of urticaria can coexist. Table I presents a
classi®cation for clinical use. As is evident, there are some
inconsistencies in this classi®cation, e.g., physical urticarias are
also of a chronic nature. They are, nevertheless, grouped separately
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due to the special nature of their eliciting physical factors, whereas
in acute and chronic urticaria wheals arise spontaneously without
external physical stimuli. In addition, for historic reasons, some
disease entities have been included under the heading ``urticaria'',
although they do not ful®l the strict de®nitions for wheals or
angioedema, such as urticaria pigmentosa, urticarial vasculitis, and
familial cold urticaria, where both reactions represent typical
vasculitis.
Another important de®ning factor in urticaria is disease severity.
In the different subtypes of physical urticaria an exact measurement
of the intensity of the eliciting factor can be made, e.g., the
temperature and time of application in cold urticaria or the pressure
and time of application until provocation of lesions in delayed
pressure urticaria. For acute and chronic urticaria assessing severity
is more complex. In the past, different point scoring systems have
been proposed ranging from 0 to 3 and up to 10. In order to
improve comparison of study results from different centers a uni®ed
scoring system is required.
We propose a simple scoring system that is suitable for both the
patient's daily evaluation and the doctor's evaluation at the time of
the patient's visit (Table II). Due to the change in intensity during
the day, a 24 h patient self-evaluation score represents probably the
most exact parameter for assessing the overall intensity of the
disease. In addition, a single time point evaluation by the treating
physician, based primarily on visible symptoms at the time of the
patient's visit, helps to make the patient score more objective. Due
to diurnal rhythms in urticaria intensity, sequential physical
examinations should be performed at the same time of day.
Other aspects that have received insuf®cient attention in the past
are interpatient and within-patient differences in the appearance of
wheals before and after treatment. In general, larger wheals indicate
a more severe and dif®cult to treat disease.
An important aspect is the color of the wheals. Histamine-
induced wheals are of light color, surrounded by a pink erythema
Table I. Classi®cation of urticaria on the basis of its duration, frequency and causes
duration frequency
a. spontaneous urticaria
1. acute urticaria
2. chronic urticaria
± chronic continuous urticaria
± chronic recurrent urticaria
b. physical urticaria
1. dermographic urticaria
2. delayed pressure urticaria
3. cold contact urticaria
4. heat contact urticaria
5. solar urticaria
6. vibratory urticaria/angioedema
c. special types of urticaria
1. cholinergic urticaria
2. adrenergic urticaria
3. contact urticaria (allergic or pseudoallergic)
4. aquagenic urticaria
d. different diseases related to urticaria for
historical reasons
4. urticaria pigmentosa (mastocytosis)
5. urticarial vasculitis
< 6 wk
> 6 wk
daily or on most days of the week
symptom free intervals ranging from days to weeks
eliciting factor
mechanical shearing forces (wheals arising after 1±5 min)
vertical pressure (wheals arising with a 3±8 h latency)
cold air/water/wind
localized heat
UV and/or visible light
vibratory forces, e.g., pneumatic hammer
spontaneous wheals appearing most days
spontaneous appearance of wheals
6. familial cold urticaria (a vasculitis)
Table II. Assessment of disease intensity
Scorea Wheals Pruritus
0 none none
1 mild mild
(< 20 wheals/24 h)
2 moderate moderate
(21±50 wheals/24 h)
3 intense intense
(> 50 wheals/24 h, or
large con¯uent areas of wheals)
aSum of score: (0±6).
Table III. Possible mechanisms for urticaria
Mechanism Examples
a. immunologic
1. antigen-induced drug allergy food allergy insect allergy
2. immunoglobulin-
mediated;
unknown antigen
some physical urticarias
(cold, dermographic, solar)
3. autoimmune chronic idiopathic urticaria with
IgE-receptor or thyroid autoantibodies,
SLE,rheumatic fever
b. infectious
1. viral diseases hepatitis A or B, CMV, Coxsackie viruses
2. bacterial diseases helicobacter pylori, streptococci
3. fungal infections trichophyton, candida
4. parasites giardia lamblia, entamoeba, trichinella
c. pseudoallergic
1. complement mediated heat urticaria hereditary angiedema reactions
to blood products
2. unknown NSAID, food
d. other
1. histamine releasing
chemicals
polycations codeine polymyxin B
2. internal diseases tumors, sarcoidosis
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Figure 1. Flow sheet as an aide in the stepwise procedure for the diagnosis of urticaria.
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due to dilatation of cutaneous vessels. If wheals are of a dark red or
violaceous color, as, for example, in urticarial vasculitis, this
indicates intense vascular damage and leakage in association with
wheal formation. It would also be desirable to assess the size and
color of wheals in the scoring system, but as these parameters are
dif®cult to quantify they are not included.
POSSIBLE MECHANISMS IN URTICARIA
In the last two decades many advances have been made to identify
causes of different types and subtypes of urticaria underlining the
heterogeneity of the disease even in one subtype, e.g., chronic
urticaria. Among others, infections, pseudoallergy against food, and
IgE receptor autoantibodies have been repeatedly described (Juhlin,
1981; Hide et al, 1993; Zuberbier et al, 1995; Fiebiger et al, 1998;
Greaves, 2000); however, in different studies there is considerable
variation in the frequency of eliciting factors. One cause for this
may be due to differences in patient selection, underlining the
necessity for a consensus in the precise patient selection data to
enable comparison of results between different patient groups to be
made.
Attempts to classify urticaria on the basis of underlying
mechanisms have been made in the past. This is not practised in
the clinic and the panel as well as the participants decided not to use
such a classi®cation, due to many overlaps between urticaria types.
To avoid confusion only the classi®cation outlined in Table I
should be used for routine purposes; however, to increase
awareness of the possible mechanisms involved and to clarify the
largely idiopathic forms of urticaria, a list of possible pathomechan-
isms with examples is given in Table III. The relevance of the
items listed is variable and depends on the subtype of urticaria.
DIAGNOSIS OF URTICARIA
Due to the heterogeneity of the disease and its many subtypes,
guidelines for diagnosis can only cover a routine programme,
including a thorough history and physical examination as well as
speci®c provocation and laboratory tests on the basis of the
suspected cause.
Of all diagnostic procedures, a thorough history including all
possible eliciting factors and signi®cant aspects as to the nature of
the urticaria is of paramount importance. The questions that should
be asked include the following items (Henz et al, 1998):
(1) time of onset of disease;
(2) frequency and duration of whealing;
(3) diurnal variation;
(4) shape, size, and distribution of wheals;
(5) associated angiedema;
(6) associated subjective symptoms of lesion, e.g., itch, pain;
(7) family history regarding urticaria, atopy;
(8) previous or currently existing allergies, infections, internal
diseases, or other possible causes;
(9) induction by physical agents or exercise;
(10) use of drugs (NSAID, injections, immunizations, hormones,
laxatives, supposatories, ear and eye drops, and alternative
remedies);
(11) food;
(12) smoking habits;
(13) type of work;
(14) hobbies;
(15) occurrence in relation to weekends, holidays and foreign
travel;
(16) surgical implantations;
(17) reactions to insect stings;
(18) relationship to the menstrual cycle;
(19) response to therapy;
(20) stress;
(21) quality of life related to urticaria.
The second step is the physical examination of the patient. This
should include a test for dermographism when the patient has
ceased antihistamine therapy for at least 2 d. The subsequent
diagnostic steps depend on the nature of the urticaria subtype and
are summarized in the ¯ow sheet (Fig 1).
The panel strongly advises against intense and costly general
screening programmes for urticaria. Standardized diagnostic tests
for a number of urticaria subtypes are summarized in Table IV.
Additional tests should be reserved for selected patients. Type I
allergy is a rare cause in chronic continuous urticaria but must be
considered in chronic intermittent urticaria, whereas pseudoallergy
to food or food additives may be more important for chronic
continuous urticaria. The frequency and relevance of infectious
diseases varies between different patient groups and in different
regions. For example, the participants pointed out that hepatitis
virus infections are a frequent cause for chronic urticaria in
southern Europe but a rare cause in northern Europe. The necessity
to investigate dental or ENT infections appears to vary between
patient groups.
Table IV. Standard diagnostic programmea
Routine diagnostic tests
a. acute urticaria no routine diagnostic tests (unless strongly suggested by patient history)
b. chronic urticaria differential blood count
ESR (as indication of severe systemic disease)
omission of suspected drugs, e.g. NSAID
possibly: autologous serum skin test, test for helicobacter, gastroscopy, ANA, stool for
worm eggs/parasites, skin tests, speci®c IgE, thyroid hormones and autoantibodies
pseudoallergen-free diet for 3 weeks
c. physical urticaria
1. dermographic urticaria elicit dermographism differential blood count and ESR (as indication of severe systemic disease)
2. delayed pressure urticaria pressure test (0.2±0.4 kg per cm2 for 10 and 20 min)
3. cold urticaria cold provocation test (ice cube, cold water), use different temperatures to identify threshold
possibly: exposure to cold wind (ventilator), differential, ESR, cryoglobulins
4. heat contact urticaria warm arm bath (42°C; vary temperature to detect threshold)
5. solar urticaria UV and visible light of different wave lengths
d. special types of urticaria
cholinergic urticaria
exercise or hot bath according to patient history
e. other diseases
urticarial vasculitis
biopsy, differential, ESR, ANA, biochemistry urine test
aThis table gives a selection of frequent urticaria subtypes to be considered in diagnosis or differential diagnosis.
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Currently, the only generally available test to screen for
autoantibodies against the IgE receptor is the autologous serum
skin test. Both the panel and the participants advised that the test
should be performed with the utmost care, as infections (e.g., HIV,
hepatitis) could be transmitted particularly if, by mistake, patients
were not injected with their own serum.
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